T2 Biosystems Inc.

OTC: TTOO · Real-Time Price · USD
0.13
0.01 (8.79%)
At close: Apr 04, 2025, 3:42 PM

T2 Biosystems Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-50.08M -62M -49.24M
Depreciation & Amortization
859K 2.27M 2.54M
Stock-Based Compensation
4.35M 6.49M 7.09M
Other Working Capital
-4.27M -959K -957K
Other Non-Cash Items
773K 3.11M 3.93M
Deferred Income Tax
n/a n/a -1.02M
Change in Working Capital
-4.04M -503K -2.17M
Operating Cash Flow
-48.14M -50.63M -38.87M
Capital Expenditures
-192K -339K -460K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a 10M 25.25M
Other Investing Acitivies
n/a 10M 25.25M
Investing Cash Flow
-192K 9.66M 24.79M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a -330K n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-43K -78K 567K
Financial Cash Flow
52.69M 29.05M 20.54M
Net Cash Flow
4.36M -11.92M 6.45M
Free Cash Flow
-48.33M -50.97M -39.33M